25 XP   0   0   10

Graphite Bio Inc
Buy, Hold or Sell?

Let's analyse Graphite Bio Inc together

PenkeI guess you are interested in Graphite Bio Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Graphite Bio Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Graphite Bio Inc

I send you an email if I find something interesting about Graphite Bio Inc.

Quick analysis of Graphite Bio Inc (30 sec.)










What can you expect buying and holding a share of Graphite Bio Inc? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$3.15
Expected worth in 1 year
$1.22
How sure are you?
15.4%

+ What do you gain per year?

Total Gains per Share
$-1.94
Return On Investment
-3.9%

For what price can you sell your share?

Current Price per Share
$50.00
Expected price per share
$30.03 - $
How sure are you?
50%

1. Valuation of Graphite Bio Inc (5 min.)




Live pricePrice per Share (EOD)

$50.00

Intrinsic Value Per Share

$-42.96 - $-51.13

Total Value Per Share

$-39.81 - $-47.97

2. Growth of Graphite Bio Inc (5 min.)




Is Graphite Bio Inc growing?

Current yearPrevious yearGrowGrow %
How rich?$183.5m$328.1m-$106.1m-47.8%

How much money is Graphite Bio Inc making?

Current yearPrevious yearGrowGrow %
Making money-$30.5m-$24.1m-$6.4m-21.0%
Net Profit Margin-56.0%0.0%--

How much money comes from the company's main activities?

3. Financial Health of Graphite Bio Inc (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#268 / 1010

Most Revenue
#418 / 1010

Most Profit
#802 / 1010

Most Efficient
#536 / 1010

What can you expect buying and holding a share of Graphite Bio Inc? (5 min.)

Welcome investor! Graphite Bio Inc's management wants to use your money to grow the business. In return you get a share of Graphite Bio Inc.

What can you expect buying and holding a share of Graphite Bio Inc?

First you should know what it really means to hold a share of Graphite Bio Inc. And how you can make/lose money.

Speculation

The Price per Share of Graphite Bio Inc is $50.00. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Graphite Bio Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Graphite Bio Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $3.15. Based on the TTM, the Book Value Change Per Share is $-0.48 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.38 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Graphite Bio Inc.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.39-0.8%-0.54-1.1%-0.43-0.9%-0.48-1.0%-0.48-1.0%
Usd Book Value Change Per Share-0.35-0.7%-0.48-1.0%-0.38-0.8%0.240.5%0.240.5%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.35-0.7%-0.48-1.0%-0.38-0.8%0.240.5%0.240.5%
Usd Price Per Share18.34-17.76-25.10-45.25-45.25-
Price to Earnings Ratio-11.65--9.53--14.44--35.07--35.07-
Price-to-Total Gains Ratio-52.26--43.15--66.58--37.09--37.09-
Price to Book Ratio5.82-4.78-4.43-7.67-7.67-
Price-to-Total Gains Ratio-52.26--43.15--66.58--37.09--37.09-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share50
Number of shares20
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.480.24
Usd Total Gains Per Share-0.480.24
Gains per Quarter (20 shares)-9.684.85
Gains per Year (20 shares)-38.7119.40
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-39-490199
20-77-8803928
30-116-12705847
40-155-16607866
50-194-20509785
60-232-2440116104
70-271-2830136123
80-310-3220155142
90-348-3610175161
100-387-4000194180

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%0.013.00.00.0%0.013.00.00.0%0.013.00.00.0%
Book Value Change Per Share0.04.00.00.0%2.010.00.016.7%2.011.00.015.4%2.011.00.015.4%2.011.00.015.4%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.013.00.0%0.00.013.00.0%0.00.013.00.0%
Total Gains per Share0.04.00.00.0%2.010.00.016.7%2.011.00.015.4%2.011.00.015.4%2.011.00.015.4%

Fundamentals of Graphite Bio Inc

About Graphite Bio Inc

As of March 21, 2024, Graphite Bio, Inc. was acquired by LENZ Therapeutics, Inc., in a reverse merger transaction. Graphite Bio, Inc., a clinical-stage gene editing company, engages in developing therapies for serious and life-threatening diseases in the United States. The company offers GPH102 for the treatment of beta-thalassemia; and GPH201 for the treatment of XSCID, a life-threatening disease for multiple mutations in a single gene. It also offers GPH301, a product candidate for the treatment of Gaucher disease, a genetic disorder that results in a deficiency in the glucocerebrosidase enzyme. The company was formerly known as Integral Medicines, Inc., and changed its name to Graphite Bio, Inc. in August 2020. Graphite Bio, Inc. was incorporated in 2017 and is based in South San Francisco, California.

Fundamental data was last updated by Penke on 2024-04-11 10:19:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is very efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is fair priced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Graphite Bio Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Graphite Bio Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Graphite Bio Inc to the Biotechnology industry mean.
  • A Net Profit Margin of -223.9% means that $-2.24 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Graphite Bio Inc:

  • The MRQ is -223.9%. The company is making a huge loss. -2
  • The TTM is -56.0%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-223.9%TTM-56.0%-167.9%
TTM-56.0%YOY--56.0%
TTM-56.0%5Y-17.2%-38.8%
5Y-17.2%10Y-17.2%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-223.9%-200.1%-23.8%
TTM-56.0%-216.8%+160.8%
YOY--288.3%+288.3%
5Y-17.2%-449.1%+431.9%
10Y-17.2%-605.5%+588.3%
1.1.2. Return on Assets

Shows how efficient Graphite Bio Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Graphite Bio Inc to the Biotechnology industry mean.
  • -12.2% Return on Assets means that Graphite Bio Inc generated $-0.12 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Graphite Bio Inc:

  • The MRQ is -12.2%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -11.7%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-12.2%TTM-11.7%-0.5%
TTM-11.7%YOY-6.9%-4.7%
TTM-11.7%5Y-29.2%+17.5%
5Y-29.2%10Y-29.2%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-12.2%-13.3%+1.1%
TTM-11.7%-12.8%+1.1%
YOY-6.9%-11.7%+4.8%
5Y-29.2%-13.9%-15.3%
10Y-29.2%-15.7%-13.5%
1.1.3. Return on Equity

Shows how efficient Graphite Bio Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Graphite Bio Inc to the Biotechnology industry mean.
  • -12.5% Return on Equity means Graphite Bio Inc generated $-0.12 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Graphite Bio Inc:

  • The MRQ is -12.5%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -14.0%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-12.5%TTM-14.0%+1.5%
TTM-14.0%YOY-7.4%-6.6%
TTM-14.0%5Y-7.6%-6.4%
5Y-7.6%10Y-7.6%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-12.5%-16.9%+4.4%
TTM-14.0%-16.1%+2.1%
YOY-7.4%-15.1%+7.7%
5Y-7.6%-19.3%+11.7%
10Y-7.6%-20.2%+12.6%

1.2. Operating Efficiency of Graphite Bio Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Graphite Bio Inc is operating .

  • Measures how much profit Graphite Bio Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Graphite Bio Inc to the Biotechnology industry mean.
  • An Operating Margin of -142.7% means the company generated $-1.43  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Graphite Bio Inc:

  • The MRQ is -142.7%. The company is operating very inefficient. -2
  • The TTM is -35.7%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-142.7%TTM-35.7%-107.0%
TTM-35.7%YOY--35.7%
TTM-35.7%5Y-11.0%-24.7%
5Y-11.0%10Y-11.0%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-142.7%-296.2%+153.5%
TTM-35.7%-232.5%+196.8%
YOY--298.2%+298.2%
5Y-11.0%-492.1%+481.1%
10Y-11.0%-632.4%+621.4%
1.2.2. Operating Ratio

Measures how efficient Graphite Bio Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 1.43 means that the operating costs are $1.43 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Graphite Bio Inc:

  • The MRQ is 1.427. The company is inefficient in keeping operating costs low. -1
  • The TTM is 0.357. The company is very efficient in keeping operating costs low. +2
Trends
Current periodCompared to+/- 
MRQ1.427TTM0.357+1.070
TTM0.357YOY-+0.357
TTM0.3575Y0.110+0.247
5Y0.11010Y0.1100.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.4273.231-1.804
TTM0.3573.310-2.953
YOY-3.890-3.890
5Y0.1105.739-5.629
10Y0.1107.876-7.766

1.3. Liquidity of Graphite Bio Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Graphite Bio Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 39.20 means the company has $39.20 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Graphite Bio Inc:

  • The MRQ is 39.196. The company is very able to pay all its short-term debts. +2
  • The TTM is 24.390. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ39.196TTM24.390+14.805
TTM24.390YOY24.295+0.095
TTM24.3905Y26.122-1.732
5Y26.12210Y26.1220.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ39.1963.890+35.306
TTM24.3904.173+20.217
YOY24.2955.344+18.951
5Y26.1226.126+19.996
10Y26.1226.448+19.674
1.3.2. Quick Ratio

Measures if Graphite Bio Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Graphite Bio Inc to the Biotechnology industry mean.
  • A Quick Ratio of 38.75 means the company can pay off $38.75 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Graphite Bio Inc:

  • The MRQ is 38.745. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 30.793. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ38.745TTM30.793+7.952
TTM30.793YOY40.566-9.773
TTM30.7935Y32.956-2.162
5Y32.95610Y32.9560.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ38.7453.514+35.231
TTM30.7933.998+26.795
YOY40.5665.380+35.186
5Y32.9566.105+26.851
10Y32.9566.404+26.552

1.4. Solvency of Graphite Bio Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Graphite Bio Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Graphite Bio Inc to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.03 means that Graphite Bio Inc assets are financed with 2.6% credit (debt) and the remaining percentage (100% - 2.6%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Graphite Bio Inc:

  • The MRQ is 0.026. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.147. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.026TTM0.147-0.121
TTM0.147YOY0.056+0.091
TTM0.1475Y0.483-0.336
5Y0.48310Y0.4830.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0260.339-0.313
TTM0.1470.336-0.189
YOY0.0560.271-0.215
5Y0.4830.366+0.117
10Y0.4830.389+0.094
1.4.2. Debt to Equity Ratio

Measures if Graphite Bio Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Graphite Bio Inc to the Biotechnology industry mean.
  • A Debt to Equity ratio of 2.7% means that company has $0.03 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Graphite Bio Inc:

  • The MRQ is 0.027. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.184. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.027TTM0.184-0.157
TTM0.184YOY0.059+0.124
TTM0.1845Y0.083+0.101
5Y0.08310Y0.0830.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0270.388-0.361
TTM0.1840.402-0.218
YOY0.0590.335-0.276
5Y0.0830.426-0.343
10Y0.0830.461-0.378

2. Market Valuation of Graphite Bio Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Graphite Bio Inc generates.

  • Above 15 is considered overpriced but always compare Graphite Bio Inc to the Biotechnology industry mean.
  • A PE ratio of -11.65 means the investor is paying $-11.65 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Graphite Bio Inc:

  • The EOD is -31.764. Based on the earnings, the company is expensive. -2
  • The MRQ is -11.651. Based on the earnings, the company is expensive. -2
  • The TTM is -9.529. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-31.764MRQ-11.651-20.113
MRQ-11.651TTM-9.529-2.122
TTM-9.529YOY-14.442+4.914
TTM-9.5295Y-35.072+25.544
5Y-35.07210Y-35.0720.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-31.764-2.264-29.500
MRQ-11.651-2.629-9.022
TTM-9.529-2.680-6.849
YOY-14.442-4.145-10.297
5Y-35.072-6.257-28.815
10Y-35.072-6.254-28.818
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Graphite Bio Inc:

  • The EOD is -15.850. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -5.814. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -12.247. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-15.850MRQ-5.814-10.036
MRQ-5.814TTM-12.247+6.433
TTM-12.247YOY-15.384+3.137
TTM-12.2475Y-37.687+25.440
5Y-37.68710Y-37.6870.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-15.850-2.973-12.877
MRQ-5.814-3.333-2.481
TTM-12.247-3.553-8.694
YOY-15.384-5.605-9.779
5Y-37.687-8.376-29.311
10Y-37.687-8.865-28.822
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Graphite Bio Inc is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 5.82 means the investor is paying $5.82 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Graphite Bio Inc:

  • The EOD is 15.861. Based on the equity, the company is expensive. -2
  • The MRQ is 5.818. Based on the equity, the company is overpriced. -1
  • The TTM is 4.779. Based on the equity, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD15.861MRQ5.818+10.043
MRQ5.818TTM4.779+1.038
TTM4.779YOY4.430+0.350
TTM4.7795Y7.674-2.895
5Y7.67410Y7.6740.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD15.8611.896+13.965
MRQ5.8182.115+3.703
TTM4.7792.093+2.686
YOY4.4302.884+1.546
5Y7.6743.542+4.132
10Y7.6743.916+3.758
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Graphite Bio Inc.

3.1. Institutions holding Graphite Bio Inc

Institutions are holding 84.43% of the shares of Graphite Bio Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31EcoR1 Capital, LLC14.66160.5808853844600
2023-12-31Samsara BioCapital, LLC14.52573.4479845931400
2023-09-30TANG CAPITAL MANAGEMENT LLC3.46280.70572016626-68999-3.3083
2023-12-31BlackRock Inc3.02220.00011760019-44568-2.4697
2023-12-31Nantahala Capital Management, LLC2.81940.1287164194216419420
2023-12-31Vanguard Group Inc2.44860.00011425980415142.9986
2023-12-31Prosight Management, LP2.32141.42211351939141131.0549
2023-09-30Citadel Advisors Llc2.13350.00071242459381643.169
2023-12-31Board of Ttees Leland Stanford Jr Univ1.20730.119470307100
2023-12-31Renaissance Technologies Corp0.99790.0024581156316756119.8018
2023-12-31Geode Capital Management, LLC0.95330.0002555153175623.2668
2023-12-31BML Capital Management LLC0.76830.88794474164474160
2023-12-31Sectoral Asset Management Inc0.75870.49854418294418290
2023-12-31State Street Corporation0.7460.0001434467-2000-0.4582
2023-09-30OUP Management Co., LLC0.69772.266140630800
2023-12-31Northern Trust Corp0.47940.00012791943377313.7613
2023-09-30CHI Advisors LLC0.39650.22723093800
2023-12-31Morgan Stanley - Brokerage Accounts0.35160.00012047785881540.2945
2023-12-31Acuitas Investments, LLC0.33410.3242194578-1184-0.6048
2023-09-30Jacobs Levy Equity Management, Inc.0.31950.002718604800
Total 53.405510.614831101661+2935133+9.4%

3.2. Funds holding Graphite Bio Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-02-29Vanguard Total Stock Mkt Idx Inv1.66390.000296900900
2023-09-30Galileo - Biotech Innovation Fund S USD0.51162.440929794400
2024-02-29Vanguard Institutional Extnd Mkt Idx Tr0.50350.00129324158002.0178
2024-01-31Fidelity Small Cap Index0.46550.003271122179697.0981
2023-12-31Protea Sectoral Hlthcare Opps P USD Acc0.27860.45491622611622610
2024-02-29State St Russell Sm/Mid Cp® Indx NL Cl C0.2660.001315490000
2024-02-29Fidelity Extended Market Index0.26230.0014152770-740-0.4821
2023-12-31Bridgeway Ultra-Small Company Market0.24610.202114335000
2024-02-29Vanguard Russell 2000 ETF0.17220.003610027878328.472
2023-12-31NT R2000 Value Index Fund - NL0.12430.00572386-10823-13.007
2023-12-31NT R2000 Index Fund - NL0.12340.002671873-10638-12.8928
2024-02-29Schwab Small Cap Index0.110.00376404500
2024-02-29iShares Russell 2000 Small-Cap Idx Instl0.09910.00435769100
2023-12-31NT R2000 Index Fund - DC - NL - 20.09720.002656601-8628-13.2272
2023-12-31Protea Sectoral Biotech Opps IF USD Acc0.09440.49755000550000
2023-12-31NT R2000 Value Index Fund - L0.09170.00545337500
2023-12-31Northern Trust Russell 2000 Value Index0.09170.00545337500
2024-02-29Fidelity Total Market Index0.08860.00025162700
2024-02-29Dimensional Global Trgtd Value USD Acc0.08110.00324725100
2024-01-31TIAA-CREF Small-Cap Blend Idx Inst0.06630.00323858900
Total 5.43753.6413166688+218033+6.9%

3.3. Insider Transactions

Insiders are holding 9.179% of the shares of Graphite Bio Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2022-04-11Biocapital L.p. SamsaraBUY1063728.49
2022-04-11Phil GutryBUY71428.07
2022-01-24Biocapital L.p. SamsaraBUY328560.9
2022-01-21Biocapital L.p. SamsaraBUY1428562.93
2022-01-19Biocapital L.p. SamsaraBUY779564.68
2021-12-15Biocapital L.p. SamsaraBUY318971.33
2021-11-22Biocapital L.p. SamsaraBUY2881271.05
2021-10-15Biocapital L.p. SamsaraBUY32887.43
2021-10-13Biocapital L.p. SamsaraBUY648592.54
2021-10-08Biocapital L.p. SamsaraBUY1071491.84
2021-10-06Biocapital L.p. SamsaraBUY878296.81

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Graphite Bio Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.351-0.484+38%-0.377+7%0.242-245%0.242-245%
Book Value Per Share--3.1523.812-17%5.634-44%4.246-26%4.246-26%
Current Ratio--39.19624.390+61%24.295+61%26.122+50%26.122+50%
Debt To Asset Ratio--0.0260.147-82%0.056-54%0.483-95%0.483-95%
Debt To Equity Ratio--0.0270.184-86%0.059-55%0.083-68%0.083-68%
Dividend Per Share----0%-0%-0%-0%
Eps---0.394-0.535+36%-0.434+10%-0.476+21%-0.476+21%
Free Cash Flow Per Share---0.789-0.433-45%-0.406-49%-0.343-56%-0.343-56%
Free Cash Flow To Equity Per Share---0.787-0.432-45%-0.402-49%0.230-443%0.230-443%
Gross Profit Margin--0.9940.9980%1.000-1%1.000-1%1.000-1%
Intrinsic Value_10Y_max---51.126--------
Intrinsic Value_10Y_min---42.962--------
Intrinsic Value_1Y_max---1.988--------
Intrinsic Value_1Y_min---1.951--------
Intrinsic Value_3Y_max---8.362--------
Intrinsic Value_3Y_min---7.935--------
Intrinsic Value_5Y_max---17.617--------
Intrinsic Value_5Y_min---16.146--------
Market Cap2911845000.000+63%1068064746.0001034432936.250+3%1461455005.500-27%2635354117.846-59%2635354117.846-59%
Net Profit Margin---2.239-0.560-75%--100%-0.172-92%-0.172-92%
Operating Margin---1.427-0.357-75%--100%-0.110-92%-0.110-92%
Operating Ratio--1.4270.357+300%-+100%0.110+1200%0.110+1200%
Pb Ratio15.861+63%5.8184.779+22%4.430+31%7.674-24%7.674-24%
Pe Ratio-31.764-173%-11.651-9.529-18%-14.442+24%-35.072+201%-35.072+201%
Price Per Share50.000+63%18.34017.763+3%25.095-27%45.252-59%45.252-59%
Price To Free Cash Flow Ratio-15.850-173%-5.814-12.247+111%-15.384+165%-37.687+548%-37.687+548%
Price To Total Gains Ratio-142.479-173%-52.261-43.154-17%-66.580+27%-37.093-29%-37.093-29%
Quick Ratio--38.74530.793+26%40.566-4%32.956+18%32.956+18%
Return On Assets---0.122-0.117-4%-0.069-43%-0.292+140%-0.292+140%
Return On Equity---0.125-0.140+12%-0.074-41%-0.076-39%-0.076-39%
Total Gains Per Share---0.351-0.484+38%-0.377+7%0.242-245%0.242-245%
Usd Book Value--183582000.000221992750.000-17%328124750.000-44%247257769.231-26%247257769.231-26%
Usd Book Value Change Per Share---0.351-0.484+38%-0.377+7%0.242-245%0.242-245%
Usd Book Value Per Share--3.1523.812-17%5.634-44%4.246-26%4.246-26%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.394-0.535+36%-0.434+10%-0.476+21%-0.476+21%
Usd Free Cash Flow---45927000.000-25215750.000-45%-23643500.000-49%-19993230.769-56%-19993230.769-56%
Usd Free Cash Flow Per Share---0.789-0.433-45%-0.406-49%-0.343-56%-0.343-56%
Usd Free Cash Flow To Equity Per Share---0.787-0.432-45%-0.402-49%0.230-443%0.230-443%
Usd Market Cap2911845000.000+63%1068064746.0001034432936.250+3%1461455005.500-27%2635354117.846-59%2635354117.846-59%
Usd Price Per Share50.000+63%18.34017.763+3%25.095-27%45.252-59%45.252-59%
Usd Profit---22918000.000-30533750.000+33%-24116250.000+5%-27145923.077+18%-27145923.077+18%
Usd Revenue--10236000.0002559000.000+300%-+100%787384.615+1200%787384.615+1200%
Usd Total Gains Per Share---0.351-0.484+38%-0.377+7%0.242-245%0.242-245%
 EOD+5 -3MRQTTM+17 -17YOY+13 -215Y+11 -2310Y+11 -23

4.2. Fundamental Score

Let's check the fundamental score of Graphite Bio Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-31.764
Price to Book Ratio (EOD)Between0-115.861
Net Profit Margin (MRQ)Greater than0-2.239
Operating Margin (MRQ)Greater than0-1.427
Quick Ratio (MRQ)Greater than138.745
Current Ratio (MRQ)Greater than139.196
Debt to Asset Ratio (MRQ)Less than10.026
Debt to Equity Ratio (MRQ)Less than10.027
Return on Equity (MRQ)Greater than0.15-0.125
Return on Assets (MRQ)Greater than0.05-0.122
Total4/10 (40.0%)

4.3. Technical Score

Let's check the technical score of Graphite Bio Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5044.943
Ma 20Greater thanMa 5088.993
Ma 50Greater thanMa 10047.164
Ma 100Greater thanMa 20031.613
OpenGreater thanClose50.000
Total3/5 (60.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2022-12-312023-03-312023-06-302023-09-302023-12-31
Gross Profit  -2,2222-2,220122-2,0981,298-80010,89410,094



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets188,456
Total Liabilities4,874
Total Stockholder Equity183,582
 As reported
Total Liabilities 4,874
Total Stockholder Equity+ 183,582
Total Assets = 188,456

Assets

Total Assets188,456
Total Current Assets188,021
Long-term Assets435
Total Current Assets
Cash And Cash Equivalents 185,861
Other Current Assets 2,160
Total Current Assets  (as reported)188,021
Total Current Assets  (calculated)188,021
+/-0
Long-term Assets
Property Plant Equipment 321
Long-term Assets Other 114
Long-term Assets  (as reported)435
Long-term Assets  (calculated)435
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities4,797
Long-term Liabilities77
Total Stockholder Equity183,582
Total Current Liabilities
Short-term Debt 285
Accounts payable 250
Other Current Liabilities 4,262
Total Current Liabilities  (as reported)4,797
Total Current Liabilities  (calculated)4,797
+/-0
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt77
Long-term Liabilities  (as reported)77
Long-term Liabilities  (calculated)77
+/- 0
Total Stockholder Equity
Common Stock1
Retained Earnings -367,054
Other Stockholders Equity 550,635
Total Stockholder Equity (as reported)183,582
Total Stockholder Equity (calculated)183,582
+/-0
Other
Capital Stock1
Cash and Short Term Investments 185,861
Common Stock Shares Outstanding 58,008
Liabilities and Stockholders Equity 188,456
Net Debt -185,499
Net Invested Capital 183,582
Net Working Capital 183,224
Property Plant and Equipment Gross 321
Short Long Term Debt Total 362



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-31
> Total Assets 
0
0
0
22,564
182,912
387,106
416,152
401,987
378,606
353,786
334,845
321,902
309,996
287,044
266,228
188,456
188,456266,228287,044309,996321,902334,845353,786378,606401,987416,152387,106182,91222,564000
   > Total Current Assets 
0
0
0
21,103
180,266
384,752
401,229
381,736
343,756
326,644
298,492
275,365
270,307
251,171
238,783
188,021
188,021238,783251,171270,307275,365298,492326,644343,756381,736401,229384,752180,26621,103000
       Cash And Cash Equivalents 
0
0
0
19,782
177,015
381,965
394,804
376,976
185,070
75,171
56,391
47,730
69,811
128,506
182,988
185,861
185,861182,988128,50669,81147,73056,39175,171185,070376,976394,804381,965177,01519,782000
       Short-term Investments 
0
0
0
0
0
0
0
0
154,112
247,121
235,294
220,499
194,285
118,159
50,998
0
050,998118,159194,285220,499235,294247,121154,11200000000
       Other Current Assets 
0
0
0
1,286
3,102
2,638
6,276
4,760
4,574
4,352
6,807
7,136
6,211
4,506
4,797
2,160
2,1604,7974,5066,2117,1366,8074,3524,5744,7606,2762,6383,1021,286000
   > Long-term Assets 
0
0
0
1,461
2,646
2,354
14,923
20,251
34,850
27,142
36,353
46,537
39,689
35,873
27,445
435
43527,44535,87339,68946,53736,35327,14234,85020,25114,9232,3542,6461,461000
       Property Plant Equipment 
0
0
0
1,461
1,918
2,343
14,911
18,081
19,496
19,103
20,390
28,210
37,084
33,802
25,729
321
32125,72933,80237,08428,21020,39019,10319,49618,08114,9112,3431,9181,461000
       Long Term Investments 
0
0
0
0
0
0
0
0
12,927
5,988
13,403
15,322
0
0
0
0
000015,32213,4035,98812,92700000000
       Other Assets 
0
0
0
0
728
11
12
2,170
2,427
2,051
2,560
3,005
0
2,071
0
0
002,07103,0052,5602,0512,4272,17012117280000
> Total Liabilities 
0
0
0
87,972
266,989
7,922
16,020
17,937
17,307
15,330
18,392
25,611
33,772
62,898
62,209
4,874
4,87462,20962,89833,77225,61118,39215,33017,30717,93716,0207,922266,98987,972000
   > Total Current Liabilities 
0
0
0
32,048
6,393
7,858
11,272
12,143
12,765
12,068
13,524
13,043
14,341
12,270
12,537
4,797
4,79712,53712,27014,34113,04313,52412,06812,76512,14311,2727,8586,39332,048000
       Short-term Debt 
0
0
0
0
0
0
4,806
5,482
5,636
4,926
4,556
4,045
3,122
2,914
3,439
285
2853,4392,9143,1224,0454,5564,9265,6365,4824,806000000
       Accounts payable 
0
0
0
630
1,606
4,046
1,763
2,453
3,069
3,619
3,972
2,608
1,992
2,720
3,753
250
2503,7532,7201,9922,6083,9723,6193,0692,4531,7634,0461,606630000
       Other Current Liabilities 
0
0
0
31,418
4,787
3,812
452
337
4,060
3,523
4,996
6,390
9,227
55
34
4,262
4,26234559,2276,3904,9963,5234,0603374523,8124,78731,418000
   > Long-term Liabilities 
0
0
0
55,924
260,596
64
4,748
5,794
4,542
3,262
4,868
12,568
19,431
50,628
49,672
77
7749,67250,62819,43112,5684,8683,2624,5425,7944,74864260,59655,924000
       Other Liabilities 
0
0
0
0
64
64
64
0
0
0
2,417
10,819
0
0
0
0
000010,8192,4170006464640000
       Deferred Long Term Liability 
0
0
0
0
700
0
0
0
0
0
0
0
0
0
0
0
000000000007000000
> Total Stockholder Equity
0
0
0
-65,408
-84,077
379,184
400,132
384,050
361,299
338,456
316,453
296,291
276,224
224,146
204,019
183,582
183,582204,019224,146276,224296,291316,453338,456361,299384,050400,132379,184-84,077-65,408000
   Common Stock
0
0
0
0
0
1
1
1
1
1
1
1
1
1
1
1
1111111111100000
   Retained Earnings Total Equity000-266,337-242,403-217,804-193,122-167,186-141,351-122,421-107,82900000
   Accumulated Other Comprehensive Income 0-95-271-469-1,048-1,596-1,033-3090-416,152-387,106-2110000
   Capital Surplus 
0
0
0
0
0
487,012
522,552
525,400
528,793
532,610
535,852
539,741
543,029
0
0
0
000543,029539,741535,852532,610528,793525,400522,552487,01200000
   Treasury Stock0000000000000000
   Other Stockholders Equity 
0
0
0
5,183
6,434
487,012
522,552
525,400
528,793
532,610
535,852
539,741
543,029
546,067
548,249
550,635
550,635548,249546,067543,029539,741535,852532,610528,793525,400522,552487,0126,4345,183000



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue0
Cost of Revenue-2,407
Gross Profit-2,407-2,407
 
Operating Income (+$)
Gross Profit-2,407
Operating Expense-70,703
Operating Income-73,110-73,110
 
Operating Expense (+$)
Research Development29,730
Selling General Administrative40,973
Selling And Marketing Expenses0
Operating Expense70,70370,703
 
Net Interest Income (+$)
Interest Income10,539
Interest Expense-0
Other Finance Cost-0
Net Interest Income10,539
 
Pretax Income (+$)
Operating Income-73,110
Net Interest Income10,539
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-124,651-21,569
EBIT - interestExpense = -73,110
-124,651
-124,651
Interest Expense0
Earnings Before Interest and Taxes (EBIT)-73,110-124,651
Earnings Before Interest and Taxes (EBITDA)-70,703
 
After tax Income (+$)
Income Before Tax-124,651
Tax Provision-0
Net Income From Continuing Ops-126,332-124,651
Net Income-124,651
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses73,110
Total Other Income/Expenses Net-51,541-10,539
 

Technical Analysis of Graphite Bio Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Graphite Bio Inc. The general trend of Graphite Bio Inc is BULLISH with 85.7% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Graphite Bio Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (85.7%) Bearish trend (-85.7%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Graphite Bio Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: .

The bearish price targets are: 30.97 > 30.10 > 30.03.

Tweet this
Graphite Bio Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Graphite Bio Inc. The current mas is .

The long score for the Moving Averages is 13/14.
The longshort score for the Moving Averages is 12/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Graphite Bio Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Graphite Bio Inc. The current macd is 57.43.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Graphite Bio Inc price going up in the near term. +2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Graphite Bio Inc. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Graphite Bio Inc price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Graphite Bio Inc Daily Moving Average Convergence/Divergence (MACD) ChartGraphite Bio Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Graphite Bio Inc. The current adx is 38.99.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -3/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Graphite Bio Inc shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX > 25 && ADX trending down: The ADX is above 25 and indicates a strong bearish trend. The ADX is declining, the bearish trend is weakening. Could be a potential reversal to the upside. -2
Graphite Bio Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Graphite Bio Inc. The current sar is 411.78.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Graphite Bio Inc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Graphite Bio Inc. The current rsi is 44.94. The current phase is Correction in bull market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Correction in bull market: Moderate price decline, potential pause in the uptrend. Reassess the market, wait for signs of stabilization.
  • Trending down: The RSI is trending down. -1
Graphite Bio Inc Daily Relative Strength Index (RSI) ChartGraphite Bio Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Graphite Bio Inc. The current phase is Oversold in bull market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -6/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Graphite Bio Inc price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Graphite Bio Inc Daily Stochastic Oscillator ChartGraphite Bio Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Graphite Bio Inc. The current cci is -25.32449798.

Graphite Bio Inc Daily Commodity Channel Index (CCI) ChartGraphite Bio Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Graphite Bio Inc. The current cmo is -18.74073294.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Graphite Bio Inc Daily Chande Momentum Oscillator (CMO) ChartGraphite Bio Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Graphite Bio Inc. The current willr is -92.38022348.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Graphite Bio Inc Daily Williams %R ChartGraphite Bio Inc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Graphite Bio Inc.

Graphite Bio Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Graphite Bio Inc. The current atr is 43.82.

Graphite Bio Inc Daily Average True Range (ATR) ChartGraphite Bio Inc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Graphite Bio Inc. The current obv is 1,530,948.

Graphite Bio Inc Daily On-Balance Volume (OBV) ChartGraphite Bio Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Graphite Bio Inc. The current mfi is 91.98.

The long score for the Money Flow Index (MFI) is 2/2.
The longshort score for the Money Flow Index (MFI) is 2/(-2 +2).

  • MFI > 50: +1
  • MFI > 80: +1
Graphite Bio Inc Daily Money Flow Index (MFI) ChartGraphite Bio Inc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Graphite Bio Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-10-31MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-11-02STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-03MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-11-06MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-11-08MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-11-10CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-11-14STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-15CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-11-20SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-11-21STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-11-22STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-24MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-11-27WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-11-28MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-11-30STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-01STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-04STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-05CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2023-12-06STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-13MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2023-12-15STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-18STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2023-12-19STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-21STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-22DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-12-26STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-27STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-28ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-03STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-04RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-05STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-09STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-10STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-11RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-12MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-16MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-01-17SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-01-18SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-01-22STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-23CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-24RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-30MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-01-31DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-02STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-07DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-08CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-09MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-02-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-13MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-14STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-15MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-02-20DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-21STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-22DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-02-23STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-26CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-02-27STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-02-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-04RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-03-06SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-07MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-08DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-11MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-12RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-13BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-03-15SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-18SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-20STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-22DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside

6.3. Candlestick Patterns

Graphite Bio Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Graphite Bio Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5044.943
Ma 20Greater thanMa 5088.993
Ma 50Greater thanMa 10047.164
Ma 100Greater thanMa 20031.613
OpenGreater thanClose50.000
Total3/5 (60.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Graphite Bio Inc with someone you think should read this too:
  • Are you bullish or bearish on Graphite Bio Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Graphite Bio Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Graphite Bio Inc

I send you an email if I find something interesting about Graphite Bio Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Graphite Bio Inc.

Receive notifications about Graphite Bio Inc in your mailbox!